gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hering, S; Lemburg, S; Nicolas, V; Pennekamp, W; Peters, S; Roggenland, D; Schwenke, C; Sterl, S | 1 |
| Bonnet, PA; Chambon, C; Doucet, D; Fernandez, JP; Michel, A | 1 |
1 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Body Weight
| Article | Year |
|---|---|
Intra-individual, randomised comparison of the MRI contrast agents gadobutrol and gadoterate in imaging the distal lower limb of patients with known or suspected osteomyelitis, evaluated in an off-site blinded read.
Topics: Aged; Body Weight; Contrast Media; Extremities; Female; Heterocyclic Compounds; Humans; Lower Extremity; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Osteomyelitis; Prospective Studies; Time Factors | 2011 |
1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Body Weight
| Article | Year |
|---|---|
Pharmacokinetic study of gadolinium-DOTA in control and streptozocin diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Heterocyclic Compounds; Injections, Intravenous; Male; Organometallic Compounds; Rats; Rats, Wistar | 1992 |